Anette Stryhn Selected Research

Anette Stryhn Research Topics

Disease

17	Infections 01/2020 - 07/2003
4	Yellow Fever 01/2020 - 02/2015
4	Disease Progression 01/2018 - 12/2012
4	HIV Infections (HIV Infection) 01/2018 - 05/2011
4	Tuberculosis (Tuberculoses) 04/2011 - 05/2005
3	Zika Virus Infection 11/2021 - 01/2018
3	Virus Diseases (Viral Diseases) 11/2021 - 11/2004
2	Reinfection 01/2020 - 11/2004
2	Viremia 10/2013 - 05/2011
2	Neoplasms (Cancer) 11/2011 - 10/2010
1	COVID-19 01/2021
1	Dengue (Dengue Fever) 01/2020
1	Japanese Encephalitis 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Guillain-Barre Syndrome 01/2018
1	Inflammation (Inflammations) 01/2018
1	Microcephaly 01/2018
1	Malaria 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2011
1	Breast Neoplasms (Breast Cancer) 11/2011
1	Communicable Diseases (Infectious Diseases) 01/2011
1	Hematologic Neoplasms (Hematological Malignancy) 10/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2010
1	Human Influenza (Influenza) 04/2007
1	Weight Loss (Weight Reduction) 10/2004
1	Pneumonia (Pneumonitis) 10/2004
1	Lung Diseases (Lung Disease) 10/2004
1	Respiratory Syncytial Virus Infections 10/2004
1	Vesicular Stomatitis 07/2002

Drug/Important Bio-Agent (IBA)

18	EpitopesIBA 01/2020 - 10/2004
10	VaccinesIBA 11/2021 - 05/2005
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2005
6	HLA-B Antigens (HLA-B)IBA 01/2018 - 10/2010
5	Peptides (Polypeptides)IBA 01/2017 - 04/2007
4	AntigensIBA 11/2021 - 12/2006
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2020 - 01/2011
4	Antiviral Agents (Antivirals)IBA 06/2015 - 07/2002
4	HLA-A Antigens (HLA-A)IBA 11/2011 - 10/2010
3	Neutralizing AntibodiesIBA 11/2021 - 01/2020
3	HLA-B57 antigenIBA 01/2018 - 01/2012
2	AntibodiesIBA 11/2021 - 11/2011
2	HLA-B*07 antigenIBA 05/2014 - 11/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2004 - 10/2004
1	invariant chain (Ii-Key)IBA 11/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	Antiviral Restriction FactorsIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Attenuated VaccinesIBA 01/2020
1	CytokinesIBA 01/2020
1	Interferon Type IIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Lipopolysaccharide ReceptorsIBA 01/2018
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2017
1	Malaria VaccinesIBA 10/2013
1	HLA-DR Antigens (HLA-DR)IBA 10/2013
1	HLA-A*68 antigenIBA 07/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2011
1	Interleukin-2 (IL2)IBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	HLA-A*02:01 antigenIBA 01/2011
1	Mycobacterium tuberculosis antigensIBA 01/2011
1	HLA-B*07:02 antigenIBA 01/2011
1	Minor Histocompatibility AntigensIBA 10/2010
1	Viral ProteinsIBA 04/2007
1	Subunit VaccinesIBA 05/2005
1	DNA VaccinesIBA 07/2003

Therapy/Procedure

1	Highly Active Antiretroviral Therapy (HAART) 01/2018
1	Immunotherapy 11/2011
1	Aftercare (After-Treatment) 11/2011
1	Cell Transplantation 10/2010